Form 4: Kindly MD CFO Awarded Over 2.6M RSUs

Kindly MD, Inc.'s Chief Financial Officer, Teresa S. Gendron, was granted 2,624,671 restricted stock units, vesting over four years.

Summary

• Teresa S. Gendron, Chief Financial Officer of Kindly MD, Inc. (NAKA), was granted 2,624,671 restricted stock units (RSUs).
• The RSUs will time-vest over a four-year period.
• There will be no vesting during the first twelve months following December 8, 2025 (the "Cliff Period").
• Following the completion of the Cliff Period, 25% of the RSUs shall vest.
• The remaining 75% of the RSUs will vest in equal quarterly installments over the subsequent three years.
• Vesting is contingent upon Ms. Gendron's continued service to the issuer through each applicable vesting date.

Sentiment

Score: 6

Explanation: Slightly positive as it indicates executive retention and alignment of interests, which is generally viewed favorably. However, it's a routine compensation disclosure, not a performance indicator.

Positives

• The grant of restricted stock units to the Chief Financial Officer aligns management's long-term interests with those of shareholders.
• This compensation structure serves as an incentive for the CFO's continued service and performance over a four-year period.

Negatives

• The future conversion of these restricted stock units into common stock could result in dilution for existing shareholders.

Risks

• The vesting of the RSUs is subject to the reporting person's continued service to the issuer, meaning the full award may not be realized if employment ceases.
• The value of the RSUs upon vesting is dependent on the future market price of Kindly MD, Inc. common stock.

Future Outlook

The vesting schedule for the restricted stock units indicates a long-term commitment from the Chief Financial Officer, aligning her incentives with the company's performance over the next four years, starting from December 8, 2025.

Industry Context

The grant of restricted stock units is a common practice in public companies to compensate and retain key executives, aligning their interests with long-term shareholder value creation. This type of equity award is a standard component of executive compensation packages across various industries.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) with a multi-year vesting schedule, including a cliff period, is a standard compensation mechanism for executive retention and incentive in publicly traded companies, comparable to practices at similar-sized firms in the healthcare or technology sectors.
• The specific number of RSUs granted would typically be evaluated against the executive's role, company size, and peer group compensation data, though such comparative data is not provided in this filing.

Corporate Governance

Related Party Transactions

• The grant of 2,624,671 restricted stock units to Teresa S. Gendron, the Chief Financial Officer, constitutes a transaction with a related party (an insider).

Stakeholder Impact

• Shareholders: Potential for future dilution when RSUs convert to common stock; improved alignment of executive interests with long-term shareholder value.
• Employees: May signal stability in executive leadership.

Next Steps

• Continued service of the CFO to meet vesting conditions.
• Quarterly vesting of RSUs after the initial 12-month cliff period.

Key Dates

Keywords

Kindly MD, NAKA, Restricted Stock Units, RSU, Executive Compensation, CFO, Insider Transaction, Form 4, Stock Grant, Equity Award